ENDRA Life Sciences Inc. (NDRA) Stock Analysis & Investment Frameworks

ENDRA Life Sciences Inc. (NDRA) stock analysis on Invetso. Review ENDRA Life Sciences Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

ENDRA Life Sciences Inc. Company Overview

ENDRA Life Sciences Inc. Key Financial Metrics

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other diagnostic imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and conventional ultrasound. These instruments empower physicians to visualize internal anatomy, aiding in treatment guidance and the identification of various medical conditions like bone fractures, cancerous growths, indicators of heart disease, or internal bleeding. The company also maintains a research collaboration agreement with General Electric Company. Established in 2007, ENDRA Life Sciences Inc. is headquartered in Ann Arbor, Michigan.

ENDRA Life Sciences Inc. Investment Frameworks

Invetso analyzes ENDRA Life Sciences Inc. (NDRA) across the following frameworks:

Explore More NDRA Research